About us
Company
Leadership Team
Supervisory Board
Scientific Advisors
Our Pipeline
Respiratory
Respiratory platform around ACE2
Oncology
GD2 Target
Next-Generation Checkpoint Inhibition
Novel IO Targets
Science
GD2 Target
Respiratory platform around ACE2
Next-Generation Checkpoint Inhibition
Novel IO Targets
Media
Press Releases
Meet us
Downloads
Contact us
Career
APEIRON Biologics AG and Domainex Ltd announce the expansion of their partnership to progress targeted cancer immune therapy drug discovery
Integrated lead optimisation to advance APEIRON’s Cbl-b inhibitor development programme APN431
Inhibitors discovered at Domainex via virtual and fragment screening
Press release (EN)
|
Presseaussendung (DE)